| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 6.39e-11 | 43 | 165 | 9 | GO:0030280 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MICAL1 KATNAL2 WAS MAP7D3 CLIP2 MYO7B ENC1 ARFGEF2 EPB41L4A CLIP1 MYO5C SMTN SHROOM4 BICDL1 KIF15 BMP10 SIPA1L1 PHACTR3 CEP135 COBL CEP295 DLEC1 KIFC3 TRAK2 NOS3 MX2 | 1.20e-06 | 1099 | 165 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | AP-2 adaptor complex binding | 1.89e-04 | 14 | 165 | 3 | GO:0035612 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor receptor activity | 2.03e-04 | 3 | 165 | 2 | GO:0005017 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT1 KRT3 MICAL1 KRT6A KRT6B KRT7 KATNAL2 WAS MAP7D3 PDGFRA CLIP2 PDGFRB MYO7B DSP CARMIL1 RICTOR CLIP1 MYO5C SHROOM4 ARHGAP6 VIPAS39 KRT75 KRT6C BMP10 COBL CKAP2 ARAP1 | 9.49e-09 | 957 | 164 | 27 | GO:0097435 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 9.57e-08 | 99 | 164 | 9 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.04e-07 | 100 | 164 | 9 | GO:0045103 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 1.44e-07 | 75 | 164 | 8 | GO:0045109 | |
| GeneOntologyBiologicalProcess | keratinization | 4.62e-07 | 87 | 164 | 8 | GO:0031424 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 2.85e-06 | 189 | 164 | 10 | GO:0030216 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 1.77e-05 | 284 | 164 | 11 | GO:0009913 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MICAL1 WAS PDGFRA PDGFRB MYO7B CARMIL1 PCLO RICTOR EPB41L4A ARHGEF17 MYO5C SMTN SHROOM4 ARHGAP6 BMP10 SIPA1L1 PHACTR3 COBL ARAP1 | 2.21e-05 | 803 | 164 | 19 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament-based process | MICAL1 WAS PDGFRA PDGFRB MYO7B DSP CARMIL1 PCLO RICTOR EPB41L4A ARHGEF17 MYO5C SMTN SHROOM4 ARHGAP6 BMP10 SIPA1L1 PHACTR3 COBL ARAP1 | 3.91e-05 | 912 | 164 | 20 | GO:0030029 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 4.00e-05 | 9 | 164 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 5.68e-05 | 10 | 164 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | peptide cross-linking | 5.86e-05 | 27 | 164 | 4 | GO:0018149 | |
| GeneOntologyBiologicalProcess | glomerulus morphogenesis | 7.77e-05 | 11 | 164 | 3 | GO:0072102 | |
| GeneOntologyBiologicalProcess | retina vasculature development in camera-type eye | 8.99e-05 | 30 | 164 | 4 | GO:0061298 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.33e-04 | 13 | 164 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.68e-04 | 14 | 164 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus morphogenesis | 1.88e-04 | 3 | 164 | 2 | GO:0072275 | |
| GeneOntologyBiologicalProcess | metanephric glomerular capillary formation | 1.88e-04 | 3 | 164 | 2 | GO:0072277 | |
| GeneOntologyBiologicalProcess | metanephric glomerulus vasculature morphogenesis | 1.88e-04 | 3 | 164 | 2 | GO:0072276 | |
| GeneOntologyBiologicalProcess | VEGF-activated platelet-derived growth factor receptor signaling pathway | 1.88e-04 | 3 | 164 | 2 | GO:0038086 | |
| GeneOntologyBiologicalProcess | positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway | 1.88e-04 | 3 | 164 | 2 | GO:0038091 | |
| GeneOntologyBiologicalProcess | epidermis development | FLG KRT1 KRT3 KRT6A KRT6B KRT7 WAS DSP EVPL KRT75 KRT6C SLITRK6 | 3.30e-04 | 461 | 164 | 12 | GO:0008544 |
| GeneOntologyBiologicalProcess | RNA localization | 3.54e-04 | 217 | 164 | 8 | GO:0006403 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT1 KRT3 MICAL1 KRT6A KRT6B KRT7 KATNAL2 WAS CLIP2 DSP CARMIL1 ARFGEF2 EVPL CCT4 CLIP1 SMTN SHROOM4 ARHGAP6 KRT75 KIF15 KRT6C RP1L1 COBL CEP295 KIFC3 CKAP2 MX2 INVS | 3.48e-10 | 899 | 163 | 28 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KRT1 KRT3 MICAL1 KRT6A KRT6B KRT7 KATNAL2 WAS CLIP2 DSP CARMIL1 ARFGEF2 EVPL CCT4 CLIP1 SMTN SHROOM4 ARHGAP6 KRT75 KIF15 KRT6C BMP10 RP1L1 COBL CEP295 KIFC3 CKAP2 MX2 INVS | 3.33e-08 | 1179 | 163 | 29 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT1 KRT3 MICAL1 KRT6A KRT6B KRT7 KATNAL2 WAS CLIP2 DSP CARMIL1 ARFGEF2 EVPL CCT4 CLIP1 SMTN SHROOM4 ARHGAP6 KRT75 KIF15 KRT6C BMP10 RP1L1 COBL CEP295 KIFC3 CKAP2 MX2 INVS | 3.85e-08 | 1187 | 163 | 29 | GO:0099081 |
| GeneOntologyCellularComponent | intermediate filament | KRT1 KRT3 MICAL1 KRT6A KRT6B KRT7 DSP EVPL CLIP1 KRT75 KRT6C | 1.75e-06 | 227 | 163 | 11 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT1 KRT3 MICAL1 KRT6A KRT6B KRT7 DSP EVPL CLIP1 KRT75 KRT6C | 7.20e-06 | 263 | 163 | 11 | GO:0045111 |
| GeneOntologyCellularComponent | keratin filament | 1.10e-05 | 97 | 163 | 7 | GO:0045095 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.53e-05 | 8 | 163 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 5.37e-05 | 10 | 163 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | nuclear aryl hydrocarbon receptor complex | 6.04e-05 | 2 | 163 | 2 | GO:0034753 | |
| GeneOntologyCellularComponent | actin filament | 1.51e-04 | 146 | 163 | 7 | GO:0005884 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.59e-04 | 14 | 163 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | cornified envelope | 2.04e-04 | 69 | 163 | 5 | GO:0001533 | |
| GeneOntologyCellularComponent | microtubule organizing center | HMBOX1 KATNAL2 ANKS1B ARFGEF2 CCT4 CLIP1 SMTN CEP63 BICDL1 KIF15 CCNB2 CROCC2 RTRAF CEP135 CEP295 KIFC3 CKAP2 NME3 | 3.07e-04 | 919 | 163 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.48e-04 | 18 | 163 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 4.81e-04 | 20 | 163 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 5.58e-04 | 21 | 163 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | Wnt-Frizzled-LRP5/6 complex | 5.95e-04 | 5 | 163 | 2 | GO:1990851 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MICAL1 WAS MYO7B CARMIL1 DAPK1 CTTNBP2NL MYO5C SMTN SHROOM4 ARHGAP6 INTS6 SIPA1L1 COBL | 6.01e-04 | 576 | 163 | 13 | GO:0015629 |
| GeneOntologyCellularComponent | microtubule | KATNAL2 CLIP2 ARFGEF2 CCT4 CLIP1 KIF15 RP1L1 CEP295 KIFC3 CKAP2 MX2 INVS | 9.95e-04 | 533 | 163 | 12 | GO:0005874 |
| GeneOntologyCellularComponent | centrosome | HMBOX1 ANKS1B ARFGEF2 CCT4 CLIP1 CEP63 BICDL1 KIF15 CCNB2 CROCC2 RTRAF CEP135 CEP295 KIFC3 CKAP2 | 1.05e-03 | 770 | 163 | 15 | GO:0005813 |
| GeneOntologyCellularComponent | nuclear pore | 1.18e-03 | 101 | 163 | 5 | GO:0005643 | |
| GeneOntologyCellularComponent | aryl hydrocarbon receptor complex | 1.64e-03 | 8 | 163 | 2 | GO:0034751 | |
| MousePheno | enlarged stomach | 1.15e-05 | 33 | 128 | 5 | MP:0003883 | |
| MousePheno | abnormal epidermal layer morphology | KRT1 KRT6A NCOA6 KRT6B PDGFRA DSP EVPL TUFT1 ASL AHR TNFAIP3 | 3.89e-05 | 271 | 128 | 11 | MP:0001216 |
| Domain | Keratin_2_head | 1.04e-09 | 24 | 163 | 7 | IPR032444 | |
| Domain | Keratin_2_head | 1.04e-09 | 24 | 163 | 7 | PF16208 | |
| Domain | Keratin_II | 1.94e-09 | 26 | 163 | 7 | IPR003054 | |
| Domain | Intermediate_filament_CS | 1.24e-06 | 63 | 163 | 7 | IPR018039 | |
| Domain | Filament | 2.82e-06 | 71 | 163 | 7 | SM01391 | |
| Domain | IF | 3.10e-06 | 72 | 163 | 7 | PS00226 | |
| Domain | Filament | 3.41e-06 | 73 | 163 | 7 | PF00038 | |
| Domain | IF | 4.47e-06 | 76 | 163 | 7 | IPR001664 | |
| Domain | PH_dom-like | RGPD4 WAS MYO7B RGPD1 FRS3 ANKS1B EPB41L4A ARHGEF17 TIAM2 RTKN2 RGPD3 OSBPL5 WDFY3 PLCH1 ARAP1 | 5.09e-06 | 426 | 163 | 15 | IPR011993 |
| Domain | - | RGPD4 WAS MYO7B RGPD1 FRS3 ANKS1B EPB41L4A ARHGEF17 TIAM2 RTKN2 RGPD3 OSBPL5 PLCH1 ARAP1 | 8.82e-06 | 391 | 163 | 14 | 2.30.29.30 |
| Domain | Rab_bind | 2.23e-05 | 7 | 163 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 2.23e-05 | 7 | 163 | 3 | IPR032023 | |
| Domain | Prefoldin | 3.91e-05 | 72 | 163 | 6 | IPR009053 | |
| Domain | - | 7.49e-05 | 10 | 163 | 3 | 1.10.220.60 | |
| Domain | SM_dom_ATX | 7.57e-05 | 2 | 163 | 2 | IPR025852 | |
| Domain | LsmAD | 7.57e-05 | 2 | 163 | 2 | PF06741 | |
| Domain | LsmAD_domain | 7.57e-05 | 2 | 163 | 2 | IPR009604 | |
| Domain | LsmAD | 7.57e-05 | 2 | 163 | 2 | SM01272 | |
| Domain | SM-ATX | 7.57e-05 | 2 | 163 | 2 | PF14438 | |
| Domain | Grip | 1.02e-04 | 11 | 163 | 3 | SM00755 | |
| Domain | GRIP | 1.02e-04 | 11 | 163 | 3 | PF01465 | |
| Domain | Ran_BP1 | 1.36e-04 | 12 | 163 | 3 | PF00638 | |
| Domain | RANBD1 | 1.36e-04 | 12 | 163 | 3 | PS50196 | |
| Domain | GRIP_dom | 1.36e-04 | 12 | 163 | 3 | IPR000237 | |
| Domain | GRIP | 1.36e-04 | 12 | 163 | 3 | PS50913 | |
| Domain | RanBD | 1.75e-04 | 13 | 163 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 1.75e-04 | 13 | 163 | 3 | IPR000156 | |
| Domain | Ank | ANKRD35 ANKS1B DAPK1 ANKRD20A2P ANKRD20A3P ANKZF1 ANKRD20A4P ANKRD20A1 INVS | 1.81e-04 | 228 | 163 | 9 | PF00023 |
| Domain | - | ANKRD35 ANKS1B DAPK1 ANKRD20A2P ANKRD20A3P ANKZF1 ANKRD20A4P ANKRD20A1 INVS | 3.37e-04 | 248 | 163 | 9 | 1.25.40.20 |
| Domain | ANK | ANKRD35 ANKS1B DAPK1 ANKRD20A2P ANKRD20A3P ANKZF1 ANKRD20A4P ANKRD20A1 INVS | 3.68e-04 | 251 | 163 | 9 | SM00248 |
| Domain | ANK_REPEAT | ANKRD35 ANKS1B DAPK1 ANKRD20A2P ANKRD20A3P ANKZF1 ANKRD20A4P ANKRD20A1 INVS | 3.90e-04 | 253 | 163 | 9 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | ANKRD35 ANKS1B DAPK1 ANKRD20A2P ANKRD20A3P ANKZF1 ANKRD20A4P ANKRD20A1 INVS | 4.01e-04 | 254 | 163 | 9 | IPR020683 |
| Domain | ANK_REP_REGION | ANKRD35 ANKS1B DAPK1 ANKRD20A2P ANKRD20A3P ANKZF1 ANKRD20A4P ANKRD20A1 INVS | 4.01e-04 | 254 | 163 | 9 | PS50297 |
| Domain | Ankyrin_rpt | ANKRD35 ANKS1B DAPK1 ANKRD20A2P ANKRD20A3P ANKZF1 ANKRD20A4P ANKRD20A1 INVS | 5.02e-04 | 262 | 163 | 9 | IPR002110 |
| Domain | Ank_2 | ANKRD35 ANKS1B DAPK1 ANKRD20A2P ANKRD20A3P ANKRD20A4P ANKRD20A1 INVS | 6.12e-04 | 215 | 163 | 8 | PF12796 |
| Domain | - | 1.11e-03 | 6 | 163 | 2 | 3.90.1290.10 | |
| Domain | Tyr_kinase_CSF1/PDGF_rcpt | 1.11e-03 | 6 | 163 | 2 | IPR016243 | |
| Domain | Plectin | 1.54e-03 | 7 | 163 | 2 | PF00681 | |
| Domain | ZF_A20 | 1.54e-03 | 7 | 163 | 2 | PS51036 | |
| Domain | zf-A20 | 1.54e-03 | 7 | 163 | 2 | PF01754 | |
| Domain | Plectin_repeat | 1.54e-03 | 7 | 163 | 2 | IPR001101 | |
| Domain | Znf_A20 | 1.54e-03 | 7 | 163 | 2 | IPR002653 | |
| Domain | ZnF_A20 | 1.54e-03 | 7 | 163 | 2 | SM00259 | |
| Domain | PLEC | 1.54e-03 | 7 | 163 | 2 | SM00250 | |
| Domain | Tyr_kinase_rcpt_3_CS | 2.05e-03 | 8 | 163 | 2 | IPR001824 | |
| Domain | RECEPTOR_TYR_KIN_III | 2.05e-03 | 8 | 163 | 2 | PS00240 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.55e-07 | 129 | 121 | 10 | M27649 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 9.55e-06 | 87 | 121 | 7 | MM15351 | |
| Pathway | REACTOME_KERATINIZATION | 1.73e-05 | 217 | 121 | 10 | M27640 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.22e-05 | 40 | 121 | 5 | MM14945 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.06e-04 | 55 | 121 | 5 | MM14917 | |
| Pubmed | RGPD4 EFCAB5 FLG KRT1 KRT3 KRT6A KRT6B KRT7 DSP PCLO RGPD1 ANKS1B GATB CCT4 CLPX NFE2L3 KRT75 TIMM21 KRT6C SETD5 BAZ1A RGPD3 LSM14A CEP295 DLEC1 NGLY1 EEA1 PLCH1 METTL25 NIPBL CCDC158 | 4.21e-12 | 1442 | 171 | 31 | 35575683 | |
| Pubmed | SEMG1 KRT1 KRT3 KRT6A KRT6B BMP2K CCT4 CLPX USP9Y KRT75 KRT6C ARAP1 | 9.37e-09 | 266 | 171 | 12 | 19380743 | |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 1.13e-08 | 16 | 171 | 5 | 12399393 | |
| Pubmed | 1.32e-08 | 57 | 171 | 7 | 31862882 | ||
| Pubmed | 2.69e-08 | 63 | 171 | 7 | 16831889 | ||
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 3.89e-08 | 8 | 171 | 4 | 12634303 | |
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 29357356 | ||
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 17851587 | ||
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 17170733 | ||
| Pubmed | 1.17e-07 | 3 | 171 | 3 | 7543104 | ||
| Pubmed | Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin. | 1.17e-07 | 3 | 171 | 3 | 1713533 | |
| Pubmed | 2.75e-07 | 234 | 171 | 10 | 36243803 | ||
| Pubmed | 4.65e-07 | 4 | 171 | 3 | 30389720 | ||
| Pubmed | Proximity interactions among centrosome components identify regulators of centriole duplication. | 7.16e-07 | 101 | 171 | 7 | 24613305 | |
| Pubmed | 7.38e-07 | 15 | 171 | 4 | 14697343 | ||
| Pubmed | 1.16e-06 | 5 | 171 | 3 | 20301457 | ||
| Pubmed | Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12. | 1.16e-06 | 5 | 171 | 3 | 1713141 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 CARMIL1 RGPD1 CLPX CWC22 CLIP1 CTTNBP2NL TUFT1 SMTN CEP63 RTKN2 CCNB2 ARID2 RGPD3 CEP135 LSM14A KIFC3 EEA1 NIPBL ARAP1 | 1.16e-06 | 1155 | 171 | 20 | 20360068 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L NCOA6 MAP7D3 PDGFRA DSP CARMIL1 RICTOR ARHGEF17 MAP3K3 SIPA1L1 OTUD7A COBL TNFAIP3 CKAP2 R3HDM1 PLCH1 GARRE1 | 1.36e-06 | 861 | 171 | 17 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATXN2L NCOA6 DSP CARMIL1 ARFGEF2 RICTOR POLA2 CLIP1 CTTNBP2NL SMTN YEATS2 EIF2D USP42 SIPA1L1 RBM6 NIPBL | 1.57e-06 | 774 | 171 | 16 | 15302935 |
| Pubmed | 1.97e-06 | 75 | 171 | 6 | 31527668 | ||
| Pubmed | HMBOX1 FLG BCL9L NCOA6 RGPD1 ZNF485 ETV3 CCT4 CLPX POM121C MYO5C YEATS2 ARNT ZFHX4 ATXN2 ARID2 RBM6 LSM14A ZKSCAN4 R3HDM1 NIPBL GARRE1 | 2.25e-06 | 1429 | 171 | 22 | 35140242 | |
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 4.03e-06 | 7 | 171 | 3 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.03e-06 | 7 | 171 | 3 | 11353387 | |
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 30944974 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 4.03e-06 | 7 | 171 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 4.03e-06 | 7 | 171 | 3 | 17372272 | |
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 38657106 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 21205196 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 18949001 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 25187515 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 8603673 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 26632511 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 24403063 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 23818861 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 23536549 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 12191015 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 22821000 | ||
| Pubmed | 4.03e-06 | 7 | 171 | 3 | 20682751 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MAP7D3 BMP2K DSP CARMIL1 RGPD1 CCT4 CLIP1 LRP1B EIF2D CCNB2 SIPA1L1 CEP135 COBL CEP295 CKAP2 GARRE1 | 5.39e-06 | 853 | 171 | 16 | 28718761 |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 6.42e-06 | 8 | 171 | 3 | 21670213 | |
| Pubmed | 6.42e-06 | 8 | 171 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 6.42e-06 | 8 | 171 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 6.42e-06 | 8 | 171 | 3 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 6.42e-06 | 8 | 171 | 3 | 28745977 | |
| Pubmed | 9.60e-06 | 9 | 171 | 3 | 16093647 | ||
| Pubmed | Type II keratins precede type I keratins during early embryonic development. | 9.60e-06 | 9 | 171 | 3 | 16180309 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 9.60e-06 | 9 | 171 | 3 | 18394993 | |
| Pubmed | 9.60e-06 | 9 | 171 | 3 | 28100513 | ||
| Pubmed | 9.60e-06 | 9 | 171 | 3 | 17887960 | ||
| Pubmed | 9.60e-06 | 9 | 171 | 3 | 11553612 | ||
| Pubmed | 9.60e-06 | 9 | 171 | 3 | 10601307 | ||
| Pubmed | 9.60e-06 | 9 | 171 | 3 | 9733766 | ||
| Pubmed | RIP4 regulates epidermal differentiation and cutaneous inflammation. | 9.60e-06 | 9 | 171 | 3 | 19626033 | |
| Pubmed | 9.60e-06 | 9 | 171 | 3 | 28877029 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | BCL9L NCOA6 RGPD1 POM121C SORT1 ARNT ZFHX4 BAZ1A ARID2 NIPBL | 1.03e-05 | 351 | 171 | 10 | 38297188 |
| Pubmed | SEMG1 FAT3 RICTOR RSRC2 CLPX POM121C YEATS2 INTS6 ZFHX4 TIMM21 SETD5 ARID2 SIPA1L1 AHR SFXN2 CEP295 WDFY3 GARRE1 | 1.08e-05 | 1116 | 171 | 18 | 31753913 | |
| Pubmed | 1.19e-05 | 60 | 171 | 5 | 31220272 | ||
| Pubmed | 1.22e-05 | 29 | 171 | 4 | 28049658 | ||
| Pubmed | 1.22e-05 | 29 | 171 | 4 | 36800290 | ||
| Pubmed | 1.37e-05 | 10 | 171 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 1.37e-05 | 10 | 171 | 3 | 16332688 | |
| Pubmed | Generation and characterization of a Myh6-driven Cre knockin mouse line. | 1.37e-05 | 10 | 171 | 3 | 34542814 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 1.37e-05 | 10 | 171 | 3 | 8857542 | |
| Pubmed | 1.37e-05 | 10 | 171 | 3 | 21859863 | ||
| Pubmed | SECISBP2L KRT1 ATXN2L KRT6A CLIP2 DSP RSRC2 CLPX ANKZF1 CLIP1 ATXN2 BAZ1A RTRAF CSNK1G1 AHR DDX3Y LSM14A EEA1 RNASEH1 MX2 | 1.48e-05 | 1371 | 171 | 20 | 36244648 | |
| Pubmed | BCL9L KATNAL2 BMP2K RICTOR CCT4 RSRC2 ANKZF1 CTTNBP2NL INTS6 ATXN2 SETD5 BAZ1A ARID2 SIPA1L1 RTRAF RGPD3 RBM6 LSM14A CKAP2 NME3 NIPBL | 1.59e-05 | 1497 | 171 | 21 | 31527615 | |
| Pubmed | 1.87e-05 | 11 | 171 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.87e-05 | 11 | 171 | 3 | 35771867 | |
| Pubmed | 1.87e-05 | 11 | 171 | 3 | 34110283 | ||
| Pubmed | CLIP2 PDGFRB DSP ENC1 ANKS1B GPR37L1 ARFGEF2 USP9Y LRP1B CEP63 NFE2L3 OTOF SIPA1L1 RTRAF KIFC3 WDFY3 CKAP2 R3HDM1 NIPBL | 2.04e-05 | 1285 | 171 | 19 | 35914814 | |
| Pubmed | ACAA2 is a ligand-dependent coactivator for thyroid hormone receptor β1. | 2.12e-05 | 113 | 171 | 6 | 34474245 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 7488247 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 19333949 | ||
| Pubmed | The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradation. | 2.40e-05 | 2 | 171 | 2 | 19644140 | |
| Pubmed | Platelet-derived growth factor receptor expression and activation in choroid plexus tumors. | 2.40e-05 | 2 | 171 | 2 | 19717644 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8586421 | ||
| Pubmed | Curcumin suppresses the transformation of an aryl hydrocarbon receptor through its phosphorylation. | 2.40e-05 | 2 | 171 | 2 | 17880909 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8765475 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 11544480 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 7523122 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 10550543 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 10550545 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8621524 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8791539 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 28393157 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 17344284 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 20489144 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8780679 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 1847074 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 9790766 | ||
| Pubmed | Platelet-derived growth factor receptor: current views of the two-subunit model. | 2.40e-05 | 2 | 171 | 2 | 2161888 | |
| Pubmed | Roles of platelet-derived growth factor in the developing and mature nervous systems. | 2.40e-05 | 2 | 171 | 2 | 9233543 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 18331602 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 8597038 | ||
| Pubmed | Structure and dimerization properties of the aryl hydrocarbon receptor PAS-A domain. | 2.40e-05 | 2 | 171 | 2 | 24001774 | |
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 28129672 | ||
| Pubmed | 2.40e-05 | 2 | 171 | 2 | 14624252 | ||
| Interaction | KRT26 interactions | 1.42e-08 | 35 | 169 | 7 | int:KRT26 | |
| Interaction | KRT14 interactions | KRT1 KRT3 KRT6A KRT6B KRT7 DSP EVPL RICTOR KRT75 KRT6C KIFC3 INVS | 8.18e-08 | 192 | 169 | 12 | int:KRT14 |
| Interaction | KRT5 interactions | KRT1 KRT3 KRT6A KRT6B KRT7 DSP EVPL RICTOR KRT75 KRT6C KIFC3 INVS | 8.66e-08 | 193 | 169 | 12 | int:KRT5 |
| Interaction | KRT19 interactions | KRT1 KRT3 KRT6A KRT6B KRT7 DSP MYO5C CEP63 KRT75 KIF15 KRT6C CEP295 KIFC3 CKAP2 | 1.18e-07 | 282 | 169 | 14 | int:KRT19 |
| Interaction | KRT25 interactions | 4.22e-07 | 35 | 169 | 6 | int:KRT25 | |
| Interaction | PHTF1 interactions | 5.47e-07 | 20 | 169 | 5 | int:PHTF1 | |
| Interaction | KRT16 interactions | KRT1 KRT3 KRT6A KRT6B KRT7 DSP ARFGEF2 RICTOR KRT75 KRT6C KIFC3 | 8.87e-07 | 197 | 169 | 11 | int:KRT16 |
| Interaction | KRT12 interactions | 1.46e-06 | 24 | 169 | 5 | int:KRT12 | |
| Interaction | KRT38 interactions | 1.96e-06 | 172 | 169 | 10 | int:KRT38 | |
| Interaction | RGPD3 interactions | 2.57e-06 | 47 | 169 | 6 | int:RGPD3 | |
| Interaction | RNF208 interactions | 3.16e-06 | 75 | 169 | 7 | int:RNF208 | |
| Interaction | RGPD1 interactions | 3.30e-06 | 49 | 169 | 6 | int:RGPD1 | |
| Interaction | KRT84 interactions | 3.30e-06 | 49 | 169 | 6 | int:KRT84 | |
| Interaction | KRT35 interactions | 4.39e-06 | 111 | 169 | 8 | int:KRT35 | |
| Interaction | KRT28 interactions | 4.70e-06 | 30 | 169 | 5 | int:KRT28 | |
| Interaction | KRT7 interactions | 4.89e-06 | 80 | 169 | 7 | int:KRT7 | |
| Interaction | KRT6A interactions | 8.45e-06 | 160 | 169 | 9 | int:KRT6A | |
| Interaction | ANKRD20A4P interactions | 1.14e-05 | 6 | 169 | 3 | int:ANKRD20A4P | |
| Interaction | KRT18 interactions | FLG KRT1 KRT3 KRT6A KRT6B KRT7 DSP MYO5C CEP63 KRT75 KIF15 KRT6C RTRAF KIFC3 | 1.25e-05 | 419 | 169 | 14 | int:KRT18 |
| Interaction | KRT20 interactions | 1.46e-05 | 63 | 169 | 6 | int:KRT20 | |
| Interaction | ANKRD20A2P interactions | 1.98e-05 | 7 | 169 | 3 | int:ANKRD20A2P | |
| Interaction | KRT15 interactions | 1.99e-05 | 178 | 169 | 9 | int:KRT15 | |
| Interaction | KRT37 interactions | 2.14e-05 | 100 | 169 | 7 | int:KRT37 | |
| Interaction | KRT75 interactions | 2.27e-05 | 181 | 169 | 9 | int:KRT75 | |
| Interaction | RGPD4 interactions | 3.10e-05 | 22 | 169 | 4 | int:RGPD4 | |
| Interaction | KRT36 interactions | 3.68e-05 | 74 | 169 | 6 | int:KRT36 | |
| Interaction | GUSBP5 interactions | 3.97e-05 | 75 | 169 | 6 | int:GUSBP5 | |
| Interaction | KRT6C interactions | 4.28e-05 | 76 | 169 | 6 | int:KRT6C | |
| Interaction | PPP2R2B interactions | 4.80e-05 | 248 | 169 | 10 | int:PPP2R2B | |
| Interaction | KRT13 interactions | 5.58e-05 | 116 | 169 | 7 | int:KRT13 | |
| Interaction | TRIM66 interactions | 6.01e-05 | 205 | 169 | 9 | int:TRIM66 | |
| Interaction | NDC80 interactions | ATXN2L KRT6A KRT6B MYO5C CEP63 KRT75 KIF15 CCNB2 CEP135 CEP295 KIFC3 | 6.78e-05 | 312 | 169 | 11 | int:NDC80 |
| Interaction | RGPD2 interactions | 7.20e-05 | 27 | 169 | 4 | int:RGPD2 | |
| Interaction | KRT24 interactions | 8.87e-05 | 54 | 169 | 5 | int:KRT24 | |
| Interaction | ANKRD20A1 interactions | 9.10e-05 | 11 | 169 | 3 | int:ANKRD20A1 | |
| Interaction | KRT8 interactions | KRT1 KRT3 KRT6A KRT6B KRT7 DSP RICTOR OVCH1 KRT75 KIF15 KRT6C SIPA1L1 KIFC3 | 9.23e-05 | 441 | 169 | 13 | int:KRT8 |
| Interaction | KRT33B interactions | 1.33e-04 | 93 | 169 | 6 | int:KRT33B | |
| Interaction | KRT10 interactions | 1.85e-04 | 187 | 169 | 8 | int:KRT10 | |
| Interaction | KRT73 interactions | 2.00e-04 | 64 | 169 | 5 | int:KRT73 | |
| Interaction | EFNA1 interactions | 2.32e-04 | 103 | 169 | 6 | int:EFNA1 | |
| Interaction | GABRB2 interactions | 2.45e-04 | 15 | 169 | 3 | int:GABRB2 | |
| Interaction | EFNA3 interactions | 3.01e-04 | 108 | 169 | 6 | int:EFNA3 | |
| Cytoband | 12q13.13 | 6.33e-09 | 67 | 171 | 7 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.02e-04 | 423 | 171 | 8 | chr12q13 | |
| GeneFamily | Keratins, type II | 2.32e-10 | 27 | 112 | 7 | 609 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD35 ANKS1B DAPK1 ANKRD20A2P ANKRD20A3P ANKZF1 ANKRD20A4P ANKRD20A1 ARAP1 INVS | 2.63e-06 | 242 | 112 | 10 | 403 |
| GeneFamily | EF-hand domain containing|Plakins | 1.04e-03 | 8 | 112 | 2 | 939 | |
| Coexpression | GU_PDEF_TARGETS_DN | 2.26e-07 | 40 | 171 | 6 | M10480 | |
| Coexpression | DING_LUNG_CANCER_BY_MUTATION_RATE | 7.81e-06 | 20 | 171 | 4 | M1189 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | KATNAL2 MAP7D3 FAT3 PCLO ARFGEF2 EPB41L4A CWC22 CLIP1 CEP63 KIF15 BAZ1A CEP135 CEP295 PLCH1 NIPBL CDH7 | 1.96e-06 | 498 | 166 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000 | KRT6A KRT7 DSP CARMIL1 ARFGEF2 EVPL BRINP1 EPB41L4A CTTNBP2NL TUFT1 MYO5C NFE2L3 FRK KRT75 BAZ1A AHR COBL SLITRK6 PLCH1 CA8 | 3.19e-06 | 780 | 166 | 20 | gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_500 | 4.01e-05 | 25 | 166 | 4 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_500_k3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1|Control_saline / Treatment groups by lineage, cell group, cell type | MICAL1 KRT7 DSP CARMIL1 DAPK1 MYO5C RTKN2 SYTL5 COBL KIFC3 MX2 | 3.24e-10 | 198 | 171 | 11 | 85f424cd9bb3117c9e322031024aabb87696ce47 |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.76e-08 | 187 | 171 | 9 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.44e-08 | 197 | 171 | 9 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.77e-08 | 198 | 171 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_1|Control_saline / Treatment groups by lineage, cell group, cell type | 7.77e-08 | 198 | 171 | 9 | 9b161285df7a4e51618f3517cfc5b8221ba55786 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-07 | 160 | 171 | 8 | 18ae6822915d16699beb9047baeef9b006901a35 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.02e-07 | 160 | 171 | 8 | 830f17bad94de05612fe6d53d39e42a4b3f3e2f3 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.36e-07 | 177 | 171 | 8 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.55e-07 | 178 | 171 | 8 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-07 | 181 | 171 | 8 | c80ffa2ded5975a88e9a1a7d333196f95237bf0a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-07 | 184 | 171 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-07 | 184 | 171 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.85e-07 | 184 | 171 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.35e-07 | 186 | 171 | 8 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-07 | 187 | 171 | 8 | b6ecf55014f246461bf1ca12f24cb4d046661fa4 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-07 | 187 | 171 | 8 | 9fb15f24b9b364b0c4704ec98aec236eaec5411c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-07 | 187 | 171 | 8 | e6afbaed352310a1cb49571a2aae18be1f533c9a | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | NPR3 AFF3 ANKRD20A2P BRINP1 ACVRL1 SHROOM4 ARHGAP6 ANKRD20A4P | 7.45e-07 | 190 | 171 | 8 | 7f3f419fffe02934b6f27b697f7a6401072491ed |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.06e-07 | 192 | 171 | 8 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-07 | 192 | 171 | 8 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | AFF3 ANKRD20A2P ANKRD20A3P ANKRD20A8P CTTNBP2NL ANKRD20A4P FIBCD1 ANKRD20A1 | 8.06e-07 | 192 | 171 | 8 | bd3d00b094d92463b06023361a71240851a542b8 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.72e-07 | 194 | 171 | 8 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.78e-07 | 197 | 171 | 8 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | PDGFRA DAPK1 ANKRD20A2P ANKRD20A3P CTTNBP2NL FRK ANKRD20A4P ANKRD20A1 | 1.02e-06 | 198 | 171 | 8 | da84c76afe835aeee39da04b63c03549218b5d91 |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | PDGFRA DAPK1 ANKRD20A2P ANKRD20A3P CTTNBP2NL FRK ANKRD20A4P ANKRD20A1 | 1.02e-06 | 198 | 171 | 8 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.06e-06 | 199 | 171 | 8 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.06e-06 | 199 | 171 | 8 | 1c70e7d6bd25980e1b92aa1cac3f3c95d9651b4b | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.06e-06 | 199 | 171 | 8 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 200 | 171 | 8 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 200 | 171 | 8 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 200 | 171 | 8 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.10e-06 | 200 | 171 | 8 | 9a6ae40f3e17cd44ee5fd73260713b920aa2ea15 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-06 | 165 | 171 | 7 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 174 | 171 | 7 | e8440eea7c81864defa57c89e9b569ad8033e5c5 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 174 | 171 | 7 | 97d4a40b536a67fa52f055eab26106d041bf3220 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.04e-06 | 174 | 171 | 7 | f9f399244c7d12caf8118ec3117d477a39e35c3b | |
| ToppCell | Control-Epithelial_alveolar-AT_1-AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.85e-06 | 178 | 171 | 7 | 1817bc520f3d23da8c0fa09bba50ae703a820cb1 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L2-4_RORB_GRIK1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.30e-06 | 180 | 171 | 7 | fd8c2059fcb382ffbfe19e598e37a49e1d5637b5 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 7.02e-06 | 183 | 171 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 171 | 7 | 6388c47b7f1d8203e3069eba0e74107256dcae51 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-06 | 184 | 171 | 7 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.27e-06 | 184 | 171 | 7 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | AFF3 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P FIBCD1 ANKRD20A1 | 7.27e-06 | 184 | 171 | 7 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-06 | 184 | 171 | 7 | d83ae1dc64aa1b27d3b524c137567418cc0ff8c6 | |
| ToppCell | Control-Epithelial_alveolar|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.53e-06 | 185 | 171 | 7 | 3937e026add96a396122139daf8011cfbc60e75c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.36e-06 | 188 | 171 | 7 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.66e-06 | 189 | 171 | 7 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.96e-06 | 190 | 171 | 7 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.96e-06 | 190 | 171 | 7 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating2_(11)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.27e-06 | 191 | 171 | 7 | 0ba5b112a82e489f5a21966f78a403a7436ce73b | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | AFF3 ANKRD20A2P ANKRD20A3P ANKRD20A8P ANKRD20A4P FIBCD1 ANKRD20A1 | 9.27e-06 | 191 | 171 | 7 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.27e-06 | 191 | 171 | 7 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.27e-06 | 191 | 171 | 7 | 39220f4a345e328f7fa4fd462a0abeea821b3e02 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 9.59e-06 | 192 | 171 | 7 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Vein|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.59e-06 | 192 | 171 | 7 | 81baf1c4063469bb0c03a8602b40e387ba7b0dfb | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.92e-06 | 193 | 171 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.92e-06 | 193 | 171 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.92e-06 | 193 | 171 | 7 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 194 | 171 | 7 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 194 | 171 | 7 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 194 | 171 | 7 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-05 | 194 | 171 | 7 | 7a66bd7d4fc9c6db861cedd2487f241e406869d1 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 194 | 171 | 7 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.03e-05 | 194 | 171 | 7 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.03e-05 | 194 | 171 | 7 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 194 | 171 | 7 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 195 | 171 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 195 | 171 | 7 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 196 | 171 | 7 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.13e-05 | 197 | 171 | 7 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | AT2_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.16e-05 | 131 | 171 | 6 | ff4e618bd944f852bbd34438f740187aca82460f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.17e-05 | 198 | 171 | 7 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-2_Progenitor-Progenitor_AT1-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.17e-05 | 198 | 171 | 7 | 8d9858dcb21f20d0c040b22a2cae543eaebd54bc | |
| ToppCell | Control_saline-Epithelial_alveolar|Control_saline / Treatment groups by lineage, cell group, cell type | 1.17e-05 | 198 | 171 | 7 | 532b7ef4ad46fe35ad2c6bdf89f70a17f1a2e2e2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.17e-05 | 198 | 171 | 7 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-05 | 198 | 171 | 7 | d6812494874be0c14361ac2ac3e418b335bb8f55 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-05 | 199 | 171 | 7 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.21e-05 | 199 | 171 | 7 | d8f904f531bfe091b7d8caaa147ea4a03d627995 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.25e-05 | 200 | 171 | 7 | c7668e26c6b8cfa6d174b0634e43c230425faba9 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-05 | 200 | 171 | 7 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Basal_2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.25e-05 | 200 | 171 | 7 | bce9bce9eb622bc6514708d49ca4a6604043c22a | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | d70bad979299615fcba707ba21296020918705e6 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 200 | 171 | 7 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | Neuronal-Excitatory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-05 | 200 | 171 | 7 | 4409065bc7aa995354c71e0f9d6f3726cf393d6b | |
| ToppCell | distal-Epithelial-Basal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.25e-05 | 200 | 171 | 7 | 5c14f0c09bb8b3daf6d649032e888a7880c52b73 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-05 | 200 | 171 | 7 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.25e-05 | 200 | 171 | 7 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | 38c21ec379005f688df33aea65237a063c476c2e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells-Neuroepithelial_cell|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 200 | 171 | 7 | 203b9a5de4430713da01b3331e69381db449a3a0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Stem_cells|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.25e-05 | 200 | 171 | 7 | a854e19703dc920e48304541e2b06ed013292f3e | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Basal_2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-05 | 200 | 171 | 7 | 621dd6438ef6e71811d3644b75209535b7c0f8f7 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.25e-05 | 200 | 171 | 7 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | (53)_Lymphoid_DC|World / shred on Cell_type and subtype | PDGFRA BMP2K DAPK1 ANKRD20A2P ANKRD20A3P CTTNBP2NL ANKRD20A1 | 1.61e-05 | 208 | 171 | 7 | 30212cfacad94a7cc562a69efa73a31259851515 |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-05 | 147 | 171 | 6 | e99197e3c2e9d63153cc55ae62b30b8363c2267e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 3.13e-05 | 156 | 171 | 6 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-05 | 157 | 171 | 6 | 6a0aa66964eecbbc232abf1d2e6c8422e4ce69d0 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.36e-05 | 158 | 171 | 6 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | IPF-Epithelial-Ionocyte|IPF / Disease state, Lineage and Cell class | 3.61e-05 | 160 | 171 | 6 | d65d19f4fae60836bfd4303a1bb7de34e9d83e35 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.74e-05 | 161 | 171 | 6 | 22fea192cd5f6d3544533d8b10e1d74dfedf0f05 | |
| Computational | Genes in the cancer module 153. | 6.44e-07 | 34 | 101 | 6 | MODULE_153 | |
| Computational | Genes in the cancer module 68. | 3.73e-06 | 26 | 101 | 5 | MODULE_68 | |
| Computational | Keratin. | 3.73e-06 | 26 | 101 | 5 | MODULE_298 | |
| Computational | Intermediate filaments and MT. | 4.32e-04 | 68 | 101 | 5 | MODULE_438 | |
| Drug | SC-791 | 1.30e-10 | 6 | 170 | 5 | CID010291510 | |
| Drug | AGN 193109 | 1.00e-07 | 31 | 170 | 6 | CID000177238 | |
| Drug | AC1L9MJT | 1.90e-06 | 192 | 170 | 10 | CID000448959 | |
| Drug | clobestasol propionate | 6.62e-06 | 17 | 170 | 4 | CID000002791 | |
| Drug | chrysarobin | 7.86e-06 | 37 | 170 | 5 | CID000068111 | |
| Drug | 2,8-DCDD | 8.05e-06 | 6 | 170 | 3 | CID000038193 | |
| Drug | dithranol | 8.46e-06 | 18 | 170 | 4 | CID000002202 | |
| Drug | Olux | 1.32e-05 | 20 | 170 | 4 | CID000032797 | |
| Drug | NSC339663 | 1.94e-05 | 250 | 170 | 10 | CID000003892 | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; HL60; HT_HG-U133A | 1.95e-05 | 199 | 170 | 9 | 2461_UP | |
| Drug | Velcade (bortezomib | KRT1 KRT3 KRT6A KRT6B KRT7 ACVRL1 MAP3K3 KRT75 KRT6C CCNB2 TNFAIP3 NOS3 | 2.59e-05 | 374 | 170 | 12 | CID000093860 |
| Drug | MK-6 | 2.84e-05 | 24 | 170 | 4 | CID005283547 | |
| Drug | Bhg-(2-1)fuc | 3.36e-05 | 25 | 170 | 4 | CID005287784 | |
| Drug | plakin | 3.47e-05 | 82 | 170 | 6 | CID000018752 | |
| Drug | al-Badry | 3.48e-05 | 165 | 170 | 8 | CID000004545 | |
| Drug | mant-GTP | 3.53e-05 | 50 | 170 | 5 | CID000128647 | |
| Drug | teleocidin B | 3.93e-05 | 123 | 170 | 7 | CID000072425 | |
| Drug | CD-III | 4.70e-05 | 53 | 170 | 5 | CID000066693 | |
| Drug | betamethasone valerate | 5.34e-05 | 28 | 170 | 4 | CID000016533 | |
| Drug | 5,7-Dmpq | 5.54e-05 | 2 | 170 | 2 | CID000003139 | |
| Drug | 3-pyridyl)urea | 5.54e-05 | 2 | 170 | 2 | CID000202697 | |
| Drug | isocurcumenol | 5.54e-05 | 2 | 170 | 2 | CID005255901 | |
| Drug | 1-ethylpyrene | 5.54e-05 | 2 | 170 | 2 | ctd:C121407 | |
| Drug | 4-nitrophenylurea | 5.54e-05 | 2 | 170 | 2 | CID000313520 | |
| Drug | sulfur mustard | 5.59e-05 | 130 | 170 | 7 | CID000010461 | |
| Drug | homocysteine thiolactone | 5.87e-05 | 131 | 170 | 7 | CID000107712 | |
| Drug | ethylnylestradiol | KRT1 KRT3 RERG KRT6A NCOA6 KRT6B KRT7 CLIP2 RSRC2 ACVRL1 CLIP1 LRP1B SORT1 INTS6 ARNT KRT75 KRT6C OSBPL5 AHR LRP5 TNFAIP3 NOS3 CA8 | 5.94e-05 | 1251 | 170 | 23 | CID000003285 |
| Drug | cignolin | 6.14e-05 | 56 | 170 | 5 | CID000010187 | |
| Drug | C11058 | 6.46e-05 | 11 | 170 | 3 | CID000035454 | |
| Drug | 8co-myristic Acid | 6.46e-05 | 11 | 170 | 3 | CID000454062 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A | 6.96e-05 | 182 | 170 | 8 | 1951_DN | |
| Drug | 2-Formyl-Protoporphryn Ix | 8.06e-05 | 31 | 170 | 4 | CID011963946 | |
| Drug | 6-methoxy-N-(3-sulfopropyl)quinolinium | 8.56e-05 | 12 | 170 | 3 | CID000123936 | |
| Drug | FeTMPyP | 8.56e-05 | 12 | 170 | 3 | CID009853416 | |
| Disease | spinocerebellar ataxia type 2 (implicated_via_orthology) | 2.96e-05 | 2 | 161 | 2 | DOID:0050955 (implicated_via_orthology) | |
| Disease | hereditary hemorrhagic telangiectasia (implicated_via_orthology) | 8.84e-05 | 3 | 161 | 2 | DOID:1270 (implicated_via_orthology) | |
| Disease | Striate palmoplantar keratoderma | 8.84e-05 | 3 | 161 | 2 | C4707237 | |
| Disease | Pachyonychia congenita syndrome | 1.76e-04 | 4 | 161 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.76e-04 | 4 | 161 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.76e-04 | 4 | 161 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.76e-04 | 4 | 161 | 2 | C1721007 | |
| Disease | body weight | SECISBP2L GABRB3 MTIF3 ATXN2L NPR3 RGPD1 ANKS1B BRINP1 POM121C CWC22 CLIP1 LRP1B ASL FIBCD1 NIPBL CDH7 NOS3 ARAP1 | 1.91e-04 | 1261 | 161 | 18 | EFO_0004338 |
| Disease | Pachyonychia Congenita | 2.93e-04 | 5 | 161 | 2 | C0265334 | |
| Disease | oligohydramnios (biomarker_via_orthology) | 2.93e-04 | 5 | 161 | 2 | DOID:12215 (biomarker_via_orthology) | |
| Disease | retinal detachment | 6.10e-04 | 7 | 161 | 2 | EFO_0005773 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 7.30e-04 | 74 | 161 | 4 | DOID:3748 (is_marker_for) | |
| Disease | Male sterility due to Y-chromosome deletions | 8.11e-04 | 8 | 161 | 2 | C2931163 | |
| Disease | Partial chromosome Y deletion | 8.11e-04 | 8 | 161 | 2 | C1507149 | |
| Disease | Leydig cell tumor (is_marker_for) | 8.11e-04 | 8 | 161 | 2 | DOID:2696 (is_marker_for) | |
| Disease | Cornelia De Lange Syndrome | 8.11e-04 | 8 | 161 | 2 | C0270972 | |
| Disease | colon cancer (is_implicated_in) | 9.97e-04 | 36 | 161 | 3 | DOID:219 (is_implicated_in) | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 1.60e-03 | 398 | 161 | 8 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Neurodevelopmental Disorders | 1.71e-03 | 93 | 161 | 4 | C1535926 | |
| Disease | autosomal dominant cerebellar ataxia (implicated_via_orthology) | 1.88e-03 | 12 | 161 | 2 | DOID:1441 (implicated_via_orthology) | |
| Disease | left atrial volume measurement | 1.88e-03 | 12 | 161 | 2 | EFO_0600035 | |
| Disease | right ventricular stroke volume measurement | 1.88e-03 | 12 | 161 | 2 | EFO_0021817 | |
| Disease | lymphangioleiomyomatosis (is_marker_for) | 1.88e-03 | 12 | 161 | 2 | DOID:3319 (is_marker_for) | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 1.91e-03 | 45 | 161 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 1.91e-03 | 45 | 161 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | cortisol measurement, response to corticosteroid, response to synacthen | 2.22e-03 | 13 | 161 | 2 | EFO_0005843, EFO_0009175, GO_0031960 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.22e-03 | 13 | 161 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | gastroesophageal reflux disease | 2.31e-03 | 101 | 161 | 4 | EFO_0003948 | |
| Disease | urinary metabolite measurement | 2.33e-03 | 245 | 161 | 6 | EFO_0005116 | |
| Disease | coronary artery disease | NCOA6 NPR3 MAP7D3 CARMIL1 WNT9B SREBF1 ARFGEF2 ACVRL1 PKD1L3 EPB41L4A ATXN2 CARF CEP135 DLEC1 NOS3 | 2.34e-03 | 1194 | 161 | 15 | EFO_0001645 |
| Disease | tetralogy of Fallot (implicated_via_orthology) | 2.58e-03 | 14 | 161 | 2 | DOID:6419 (implicated_via_orthology) | |
| Disease | obsolete aging, cognition | 2.97e-03 | 15 | 161 | 2 | EFO_0003925, GO_0007568 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 3.00e-03 | 346 | 161 | 7 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | C-X-C motif chemokine 10 measurement | 3.05e-03 | 109 | 161 | 4 | EFO_0008056 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 3.38e-03 | 16 | 161 | 2 | C1839071 | |
| Disease | Keratoderma, Palmoplantar | 3.38e-03 | 16 | 161 | 2 | C4551675 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 3.38e-03 | 16 | 161 | 2 | cv:C1839071 | |
| Disease | coffee consumption, cups of coffee per day measurement | 3.38e-03 | 16 | 161 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 3.38e-03 | 16 | 161 | 2 | 415000 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 3.58e-03 | 56 | 161 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | neuroticism measurement, cognitive function measurement | 4.03e-03 | 566 | 161 | 9 | EFO_0007660, EFO_0008354 | |
| Disease | forced expiratory volume | ATXN2L MICAL1 NCOA6 BMP2K CARMIL1 AFF3 ARFGEF2 ARHGEF17 CEP63 CROCC2 LRP5 | 4.15e-03 | 789 | 161 | 11 | EFO_0004314 |
| Disease | Insulin Resistance | 4.34e-03 | 60 | 161 | 3 | C0021655 | |
| Disease | Insulin Sensitivity | 4.34e-03 | 60 | 161 | 3 | C0920563 | |
| Disease | body mass index, high density lipoprotein cholesterol measurement | 4.76e-03 | 19 | 161 | 2 | EFO_0004340, EFO_0004612 | |
| Disease | diet measurement | SECISBP2L GABRB3 NCOA6 KATNAL2 CARMIL1 ARFGEF2 LRP1B SMTN FRK ARID2 RBM6 EEA1 NIPBL | 5.08e-03 | 1049 | 161 | 13 | EFO_0008111 |
| Disease | reticulocyte measurement | BMP2K AFF3 ENC1 ARFGEF2 RICTOR CLIP1 USP42 ATXN2 BAZ1A RBM6 LRP5 LSM14A RNASEH1 | 5.24e-03 | 1053 | 161 | 13 | EFO_0010700 |
| Disease | cognitive function measurement | EFCAB5 ATXN2L DSP AFF3 GATB BRINP1 PKD1L3 CWC22 LRP1B FRK NEK3 PHACTR3 RBM6 EEA1 CDH7 ARAP1 | 5.34e-03 | 1434 | 161 | 16 | EFO_0008354 |
| Disease | systolic blood pressure, alcohol drinking | 5.39e-03 | 128 | 161 | 4 | EFO_0004329, EFO_0006335 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSGDLDALDKQHRTA | 56 | Q5TYW2 | |
| LTDEEGTEHLRKRNT | 386 | P35869 | |
| GNNRASHRKELRSSV | 631 | P51826 | |
| QSSADKERLARENHS | 81 | P27540 | |
| SQLEEERSRHKQLSS | 166 | Q9P2B4 | |
| TDGKTAEDLARSEQH | 641 | P53355 | |
| NGEVHQAREDKSLSE | 226 | P41214 | |
| RSGDLDARDKQHRTA | 56 | Q5CZ79 | |
| NRSGESNTHQDIEEK | 461 | O76031 | |
| DRKSGNATQSVEALH | 151 | O60477 | |
| RSGELDALDKQHRTA | 56 | Q4UJ75 | |
| ESLRQSAREKEEHTQ | 391 | P41162 | |
| RSGDLDALDKQHRTA | 56 | A0PJZ0 | |
| EKTDLTNGEHARSDS | 246 | Q9Y6D5 | |
| VRDLISDRNKSHEGT | 246 | Q68CP9 | |
| RQEKQRGLHSELGES | 146 | P37023 | |
| SASKEHQRESGVLRD | 551 | Q9UDT6 | |
| EQDSGKSLHDNLRSQ | 191 | O75879 | |
| AREAASLRQHEKTRG | 826 | Q8N283 | |
| RQTRNEKQSGDGSRH | 1866 | P20930 | |
| VNHESLKGADRSTSQ | 211 | Q8N126 | |
| HKKVGRRDSQSSNEF | 1021 | Q9NSY1 | |
| QVHALREDFREKNSS | 226 | Q6ZP65 | |
| REDFREKNSSTNQHI | 231 | Q6ZP65 | |
| RTEEEKHSAVQRQGS | 321 | Q8WWM7 | |
| EALNSRGHRESALKE | 906 | Q9NRL2 | |
| TQQEESNLGKHRELR | 516 | P17342 | |
| VDQRRHTAGKAIVDS | 341 | Q8WWK9 | |
| RVNKDASGRSTNSHQ | 331 | Q15032 | |
| STRRFLKGQDEDQVH | 566 | Q9UL03 | |
| IGERVKSASDHQRQE | 841 | O75747 | |
| RNKSQRLEGHDQVSD | 801 | Q9Y5F3 | |
| HLISDRENQVGRKDT | 606 | Q9UPP5 | |
| RSGDLDALDKQHRTA | 56 | Q5SQ80 | |
| INKGVRSAEEAERHA | 1251 | Q96PE2 | |
| SSRGHDLKISADQRA | 261 | Q96LR9 | |
| EVKNEGTNHTDDLSR | 576 | Q7Z6G8 | |
| EEDLGKRNRHSSQTS | 1031 | P16234 | |
| TAGRHGDDLRNTKQE | 366 | P48668 | |
| TNDGHRKTINVARLE | 616 | Q9NZR2 | |
| QEIEDGRASKTSLEH | 1161 | Q9NS87 | |
| AIERSSRLDGSNKSH | 106 | Q96IV0 | |
| STRKGVDHSNRNQAT | 406 | Q9NQ76 | |
| TAGRHGDDLRNTKQE | 366 | P02538 | |
| KHGDDLRNTRNEISE | 296 | P08729 | |
| KLHTGRSRNDQVVTD | 106 | P04424 | |
| RNSSEREGHSINTRE | 476 | Q99700 | |
| SNTNTHGAEERNRKL | 206 | Q8N6Q8 | |
| NTHLGKEQSRRDDLE | 221 | Q9HCP0 | |
| QTTAGRHGDDLRNTK | 401 | P12035 | |
| RHGDDLRNTKSEIIE | 406 | P12035 | |
| HSIERADKTSGRNRT | 866 | O75197 | |
| ERRSEKHRDQNSSGS | 761 | Q9HCG8 | |
| DSLRVNHNDGEESKT | 6 | Q8N187 | |
| DRLDQEHSDKFGRRS | 51 | Q6NT76 | |
| ETQERDTLNKDHGND | 256 | Q9H2K0 | |
| HQIKQEFRRGTESLD | 4126 | Q9Y6V0 | |
| SQEGAHIRRETVSKS | 301 | C9JC47 | |
| RHGDSVRNSKIEISE | 386 | P04264 | |
| TAGRHGDDLRNTKQE | 366 | P04259 | |
| HISRIRKDSGEENAH | 166 | Q8IYT4 | |
| SEDIRRTHDAKQGSE | 891 | Q92817 | |
| AEKTTESRNERHLNG | 241 | Q9Y4A8 | |
| SESLRRDHDNKQKSD | 811 | Q6KC79 | |
| KQKSDDRGESERHRG | 821 | Q6KC79 | |
| ASQKAGENQEHRRAE | 226 | Q8ND56 | |
| RAESSARVQEKHGAR | 371 | Q8TDZ2 | |
| NDRSKSESNRVDAHG | 351 | P28472 | |
| DDIAQEKRLSRGISH | 106 | Q8TE49 | |
| TKNFGTENHRENTSR | 1186 | Q6R327 | |
| RKGSHTDLESINENL | 316 | P51956 | |
| SSIKRSGSQAHEQRL | 136 | P29474 | |
| DGQENKRRRHDSSGS | 311 | A8CG34 | |
| RHADDNISKDGQEVT | 531 | O43182 | |
| ASESVENGHRKRSSR | 2026 | Q14686 | |
| NGSLRNADSEIKHST | 766 | A6NKT7 | |
| AGDSSHQKTEVNSLR | 656 | Q66GS9 | |
| FARHLEKRRDGSSQQ | 81 | P42685 | |
| GEAHGRLKEQRQLSS | 431 | Q15075 | |
| QGSRRESIAEQDRHK | 606 | A4FU69 | |
| DSQEGAHIRRETVSK | 301 | P0CG42 | |
| RSGDLDALDKQHRTA | 56 | Q5VUR7 | |
| RRKTDQAQEKHGESQ | 1191 | Q711Q0 | |
| SGRLEIDTSAQNKHN | 236 | O95393 | |
| RRASKAGEVDVEQHT | 271 | O95067 | |
| KSRDQEAGAHRTLLQ | 446 | Q9H8Y5 | |
| ALEESRRHSQGLAKQ | 1476 | H7BZ55 | |
| RGNTKNHREDRSEIE | 126 | Q96MT8 | |
| GRHRAETQEQQSRSK | 31 | O60883 | |
| DDGTARKTRHNSTDL | 476 | O43559 | |
| QRSEDNARHKQSLEE | 1301 | P15924 | |
| AAVKQRRKHSSGEQD | 936 | O15063 | |
| RENQRGSEHTVNFKA | 121 | P35219 | |
| NGSENSHLRTEKAVT | 461 | O75128 | |
| TTTSRKLDREQQAEH | 1206 | Q8TDW7 | |
| SEGLSKEQLEHRERS | 396 | Q86UU0 | |
| RRDSNLHSSTDKEQA | 226 | Q8IWC1 | |
| RFTTKDRDSDHSENN | 386 | Q8N539 | |
| TKAAEHNGNSERIEE | 1111 | Q5VZK9 | |
| HENRKSRASSGSINI | 6 | O14682 | |
| NLKHATQDDASRTRA | 211 | Q9BXX0 | |
| TGDIHATKRLDREEQ | 101 | Q9ULB5 | |
| HRSNNSLRDSTEGSK | 956 | Q5M9N0 | |
| SRRNVKDSHEVSGSL | 91 | P0C5K7 | |
| RDREEALHQFRSGKS | 476 | O15523 | |
| QSGEHLEKDLGRRSS | 1816 | Q9C0D2 | |
| SLIKARGSENERHEE | 116 | Q9Y238 | |
| DSKSGDGNRALQRHV | 91 | O95661 | |
| VRRRKAHNSGEDSDL | 456 | Q9HCS5 | |
| AHNSGEDSDLKQRRR | 461 | Q9HCS5 | |
| RHKTVGSDEAQRFLQ | 41 | Q9NRP4 | |
| LGRSRDEVTSHQKLE | 1186 | P30622 | |
| TGHSNRQSDVRIKFE | 36 | Q99759 | |
| SLADKDQGHSSRTRL | 776 | Q9HC10 | |
| THNDSRGLETDERKR | 101 | P09619 | |
| NGSLRNADSEIKHST | 756 | P0DJD0 | |
| GADVNKTDHSQRTAL | 71 | Q9Y283 | |
| KNLIHGSDSVESARR | 131 | Q13232 | |
| RAISKGDQHRATQEK | 656 | Q9H0X9 | |
| LATKHRQDSFQGRES | 301 | Q96KR7 | |
| ESHRRRAGDKNQKAS | 451 | Q8TC56 | |
| RRNRLSDGEHTDTKT | 566 | Q8IZC4 | |
| KIEDRGNLRNIHSSD | 41 | Q9Y224 | |
| EGTSQELTKSHRRNT | 291 | Q8TDW5 | |
| NLATGKRRNDSGDHS | 736 | P78332 | |
| NGSLRNADSEIKHST | 766 | Q7Z3J3 | |
| RLNSSENGEDRHKRK | 101 | Q7L4I2 | |
| KDTTRRIHVSTDQGD | 321 | Q99523 | |
| TSDEFIEKRRQGLQH | 91 | Q9Y5W9 | |
| VKDRNENEIGHSRRA | 206 | Q96NB2 | |
| RNEKEGSDAKHLQRS | 706 | Q9H5Y7 | |
| EKLREGRDASHSLNQ | 131 | P0C2Y1 | |
| AEGSRLREAQHINKS | 686 | Q9BVG8 | |
| GDHDRNLKESTEQVR | 631 | Q7RTY7 | |
| RRGHQELSIDSSKEG | 241 | Q96P88 | |
| TNREQDLLSHEQKGR | 411 | P04279 | |
| TDELHERLTSKNENG | 1421 | Q7Z443 | |
| RQKQEGAADAHTAST | 546 | Q8IUH8 | |
| DTRKRHQSDGNEIAH | 1501 | O43166 | |
| HRRKQDNISGGDSSA | 121 | Q9C0A6 | |
| HRRELFSKGDETQSD | 1076 | Q9ULL8 | |
| TVTELRNRHAQGEKT | 476 | P50991 | |
| RGHSTSSERRQNLQK | 351 | Q93073 | |
| NNKSVILEGDREHSS | 266 | Q14181 | |
| NAKRSHLGRITVENE | 136 | O43463 | |
| VGNKADLDHSRQVST | 116 | Q96A58 | |
| ASAQSRGEKRTAHNA | 316 | P36956 | |
| ESLRQDARSVHLKEG | 1006 | Q96P48 | |
| KDRHSSDERTNAQVV | 396 | Q7L1S5 | |
| QHGQESEAKASKRLR | 86 | O60930 | |
| GSGDRKRSNIDSNEH | 681 | Q7Z2D5 | |
| HESQEEIKELRSRSG | 341 | O60296 | |
| SSKLDRNLGDSLHRQ | 121 | Q9NNX1 | |
| NGKSRKRRHDSVENS | 1156 | Q9H9J4 | |
| GNSGEDQHRDKRLRT | 2551 | Q86UP3 | |
| GDSRNNSSVEDQKHL | 531 | Q8IZQ1 | |
| SQTDGTLDQVSHREK | 1036 | Q8IVF5 | |
| FHEAKRTEEQLRSSQ | 686 | P21580 | |
| QKDSENDHVLGDTRS | 2311 | Q8IWN7 | |
| KRSRAIHSSDEGEDQ | 476 | P42768 | |
| THEGREQLKSRNSFS | 81 | Q9H9C1 | |
| DRDGLFDTIQRSKNH | 2366 | O00507 | |
| SDEDSLAKRQRTHDQ | 131 | Q4KWH8 | |
| DKAFNRSDRLTQHET | 501 | Q494X3 | |
| KEDGSKQVSVHRSQR | 76 | Q9BVV7 | |
| RDEKQENHSSLVSLG | 246 | Q969J2 | |
| HQGQRSREKSKATEV | 21 | Q8N831 | |
| AKTHGDTRALELNQR | 1546 | Q6PGP7 | |
| REKSVFIQHQRADSG | 221 | Q6P9A1 | |
| RGNKDLRARADAHNT | 181 | O14905 | |
| GRAFRDNSTVLEHQK | 276 | Q8NCK3 | |
| SREDSKGLAAHRLEQ | 141 | P53814 | |
| GSHKTEQRNADLTDE | 186 | Q9ULM3 | |
| GDSTTKHDLNLSQRR | 641 | Q5TIE3 | |
| VTAGRHGDDLRNTKQ | 351 | O95678 | |
| GQIRESHQKATEELR | 391 | P20592 | |
| HRSQEEEGTQRKALE | 1251 | Q9NQX4 | |
| KQLTHNSNRHSEERG | 1716 | Q6PIF6 |